• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药新分子靶点的研究进展。

Advances in novel molecular targets for antidepressants.

机构信息

Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110041. doi: 10.1016/j.pnpbp.2020.110041. Epub 2020 Jul 16.

DOI:10.1016/j.pnpbp.2020.110041
PMID:32682872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7484229/
Abstract

Depression is the most common psychiatric illness affecting numerous people world-wide. The currently available antidepressant treatment presents low response and remission rates. Thus, new effective antidepressants need to be developed or discovered. Aiming to give an overview of novel possible antidepressant drug targets, we summarized the molecular targets of antidepressants and the underlying neurobiology of depression. We have also addressed the multidimensional perspectives on the progress in the psychopharmacological treatment of depression and on the new potential approaches with effective drug discovery.

摘要

抑郁症是影响全球众多人群的最常见精神疾病。目前可用的抗抑郁治疗方法反应率和缓解率都较低。因此,需要开发或发现新的有效抗抑郁药。为了概述新的可能的抗抑郁药物靶点,我们总结了抗抑郁药的分子靶点和抑郁症的神经生物学基础。我们还讨论了抗抑郁症的精神药理学治疗进展和具有有效药物发现的新的潜在方法的多维视角。

相似文献

1
Advances in novel molecular targets for antidepressants.抗抑郁药新分子靶点的研究进展。
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110041. doi: 10.1016/j.pnpbp.2020.110041. Epub 2020 Jul 16.
2
Neurobiology of depression and novel antidepressant drug targets.抑郁症的神经生物学与新型抗抑郁药物靶点。
Curr Pharm Des. 2012;18(36):5791-801. doi: 10.2174/138161212803523581.
3
GABA and glutamate systems as therapeutic targets in depression and mood disorders.γ-氨基丁酸(GABA)和谷氨酸系统作为抑郁症和情绪障碍的治疗靶点。
Expert Opin Ther Targets. 2005 Feb;9(1):153-68. doi: 10.1517/14728222.9.1.153.
4
The psychopharmacology of GABA synapses: update 1989.γ-氨基丁酸(GABA)突触的精神药理学:1989年更新
J Neural Transm Suppl. 1990;29:13-28. doi: 10.1007/978-3-7091-9050-0_3.
5
The olfactory bulbectomized rat as a model of depression.嗅球切除大鼠作为抑郁症模型。
Pol J Pharmacol Pharm. 1984 Sep-Oct;36(5):561-9.
6
Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain.多种抗抑郁药可增加大鼠大脑抑郁相关区域的CDP - 二酰甘油生成及磷脂酰肌醇再合成。
BMC Neurosci. 2008 Jan 24;9:12. doi: 10.1186/1471-2202-9-12.
7
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments.抑郁症中的连接改变:新型治疗方法对 GABA 和谷氨酸神经递质缺陷的影响及逆转。
Neuron. 2019 Apr 3;102(1):75-90. doi: 10.1016/j.neuron.2019.03.013.
8
New approaches to antidepressant drug discovery: beyond monoamines.抗抑郁药物研发的新方法:超越单胺类
Nat Rev Neurosci. 2006 Feb;7(2):137-51. doi: 10.1038/nrn1846.
9
A hypothesis of monoamine (5-HT) - Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery.单胺(5-HT)-谷氨酸/GABA 长神经回路假说:旨在快速发现抗抑郁药物。
Pharmacol Ther. 2020 Apr;208:107494. doi: 10.1016/j.pharmthera.2020.107494. Epub 2020 Jan 25.
10
[Antidepressants consumption in the global population in France].[法国全球人口中的抗抑郁药消费情况]
Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7.

引用本文的文献

1
Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects.难治性抑郁症与鼻内用艾司氯胺酮:西班牙关于理论方面的共识
Front Psychiatry. 2025 Aug 4;16:1623659. doi: 10.3389/fpsyt.2025.1623659. eCollection 2025.
2
Recent developments in omics studies and artificial intelligence in depression and suicide.抑郁症和自杀领域的组学研究与人工智能的最新进展。
Transl Psychiatry. 2025 Aug 11;15(1):275. doi: 10.1038/s41398-025-03497-y.
3
Advances in Antidepressant Therapy: Comparing the Efficacy of Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and Novel Agents.抗抑郁治疗的进展:比较选择性5-羟色胺再摄取抑制剂(SSRIs)、5-羟色胺-去甲肾上腺素再摄取抑制剂(SNRIs)及新型药物的疗效
Cureus. 2024 Dec 24;16(12):e76318. doi: 10.7759/cureus.76318. eCollection 2024 Dec.
4
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases.跨越表观遗传学前沿:新型组蛋白修饰与疾病的交汇点。
Signal Transduct Target Ther. 2024 Sep 16;9(1):232. doi: 10.1038/s41392-024-01918-w.
5
Role of histone deacetylase inhibitors in non-neoplastic diseases.组蛋白去乙酰化酶抑制剂在非肿瘤性疾病中的作用。
Heliyon. 2024 Jul 2;10(13):e33997. doi: 10.1016/j.heliyon.2024.e33997. eCollection 2024 Jul 15.
6
The flavonoid fisetin reduces multiple physiological risk factors for dementia.类黄酮非瑟酮可降低痴呆症的多种生理风险因素。
Neurochem Int. 2024 Sep;178:105805. doi: 10.1016/j.neuint.2024.105805. Epub 2024 Jul 14.
7
Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder.NTRK2 多态性与海马体积及重度抑郁症治疗抵抗的相关性。
Genes (Basel). 2023 Nov 3;14(11):2037. doi: 10.3390/genes14112037.
8
Novel Thiosemicarbazone Quantum Dots in the Treatment of Alzheimer's Disease Combining In Silico Models Using Fingerprints and Physicochemical Descriptors.新型硫代氨基脲量子点结合使用指纹图谱和物理化学描述符的计算机模拟模型治疗阿尔茨海默病
ACS Omega. 2023 Mar 17;8(12):11076-11099. doi: 10.1021/acsomega.2c07934. eCollection 2023 Mar 28.
9
4-F-PCP, a Novel PCP Analog Ameliorates the Depressive-Like Behavior of Chronic Social Defeat Stress Mice via NMDA Receptor Antagonism.4-氟-PCP,一种新型PCP类似物,通过拮抗NMDA受体改善慢性社会挫败应激小鼠的抑郁样行为。
Biomol Ther (Seoul). 2023 Mar 1;31(2):227-239. doi: 10.4062/biomolther.2022.159. Epub 2023 Feb 15.
10
Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood.通过整合大脑和血液中的蛋白质组和转录组来识别抑郁症的因果基因。
Mol Psychiatry. 2022 Jun;27(6):2849-2857. doi: 10.1038/s41380-022-01507-9. Epub 2022 Mar 16.

本文引用的文献

1
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.mTORC1抑制剂雷帕霉素对氯胺酮抗抑郁作用的调节
Neuropsychopharmacology. 2020 May;45(6):990-997. doi: 10.1038/s41386-020-0644-9. Epub 2020 Feb 24.
2
The influence of ketamine's repeated treatment on brain topology does not suggest an antidepressant efficacy.氯胺酮重复治疗对大脑拓扑结构的影响并不表明其具有抗抑郁作用。
Transl Psychiatry. 2020 Feb 4;10(1):56. doi: 10.1038/s41398-020-0727-8.
3
Maintaining Rapid Antidepressant Effects Following Ketamine Infusion: A Major Unmet Need.维持氯胺酮输注后的快速抗抑郁效果:一个未满足的主要需求。
J Clin Psychiatry. 2020 Feb 4;81(2):19r12859. doi: 10.4088/JCP.19r12859.
4
Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment.评估全脑连通性作为抑郁症的影像学标志物:预处理策略和安慰剂对照氯胺酮治疗的影响
Neuropsychopharmacology. 2020 May;45(6):982-989. doi: 10.1038/s41386-020-0624-0. Epub 2020 Jan 29.
5
Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis.重度抑郁症患者的外泌体通过miR-139-5p调节的神经发生参与,在小鼠中引发类似抑郁的行为。
Neuropsychopharmacology. 2020 May;45(6):1050-1058. doi: 10.1038/s41386-020-0622-2. Epub 2020 Jan 27.
6
An update on ketamine and its two enantiomers as rapid-acting antidepressants.氯胺酮及其两种对映异构体作为快速抗抑郁药的最新研究进展。
Expert Rev Neurother. 2019 Jan;19(1):83-92. doi: 10.1080/14737175.2019.1554434. Epub 2018 Dec 4.
7
Stress at its best: the 1st Munich Winter Conference On Stress.
Stress. 2018 Sep;21(5):382-383. doi: 10.1080/10253890.2018.1509814.
8
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.丁丙诺啡/纳洛酮组合对治疗重度抑郁症的阿片系统调节:两项随机对照研究。
Mol Psychiatry. 2020 Jul;25(7):1580-1591. doi: 10.1038/s41380-018-0284-1. Epub 2018 Oct 29.
9
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).静脉注射氯胺酮作为治疗抵抗性抑郁症(TRD)辅助治疗的双盲、安慰剂对照、剂量范围试验。
Mol Psychiatry. 2020 Jul;25(7):1592-1603. doi: 10.1038/s41380-018-0256-5. Epub 2018 Oct 3.
10
MicroRNAs in depression and suicide: Recent insights and future perspectives.抑郁症和自杀中的 microRNAs:最新见解与未来展望。
J Affect Disord. 2018 Nov;240:146-154. doi: 10.1016/j.jad.2018.07.075. Epub 2018 Jul 24.